Showing results (141-150 of 275) with videos related to

Sort By:
Pageof 28
Medicina (Florence, Italy)|October 1, 1990
[Decrease in notifications of AIDS dementia complex in 1989-1990 in Italy: possible role of the early treatment with zidovudine]A Chiesi, M G Agresti, L G Dally, et al.
Clinical Pharmacology and Therapeutics|September 1, 1991
Pharmacokinetics of 2',3'-dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medicationsN R Hartman, R Yarchoan, J M Pluda, et al.
The Journal of Infectious Diseases|June 26, 2001
Long-term protease inhibitor-containing therapy results in limited improvement in T cell function but not restoration of interleukin-12 production in pediatric patients with AIDSC Chougnet, S Jankelevich, K Fowke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Mechanism of paclitaxel activity in Kaposi's sarcomaC Sgadari, E Toschi, C Palladino, et al.
Journal of Virology|April 20, 2001
Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus)M Paulose-Murphy, N K Ha, C Xiang, et al.
Lancet (London, England)|September 1, 1990
Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexR Yarchoan, J M Pluda, R V Thomas, et al.
The Journal of Laboratory and Clinical Medicine|October 30, 1998
Glycocalicin levels in the plasma of HIV+ patients: an indicator of platelet turnoverS B Williams, M Sano, N Smith, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
K65R mutation of human immunodeficiency virus type 1 reverse transcriptase encodes cross-resistance to 9-(2-phosphonylmethoxyethyl)adenineZ Gu, H Salomon, J M Cherrington, et al.
Lancet (London, England)|January 17, 1987
Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidineR Yarchoan, G Berg, P Brouwers, et al.
The Journal of Experimental Medicine|March 1, 1989
Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidineC F Perno, R Yarchoan, D A Cooney, et al.
Pageof 28